In his classic monograph on fat embolism published in 1962, Sevitt wrote -"Fat embolism has always given rise to debate and controversy and even now, a hundred years after its first description there is a lack of agreement, and . . . even confusion as to its frequency, aetiology, pathogenesis, clinical significance, and its clinical effects. "I Although we have acquired a greater knowledge and better understanding of this condition over the past twenty years, our ignorance is still considerable. One facet that has received little consideration and remains controversial is the fulminant form of the fat embolism syndrome.
Blockage of blood vessels by fat globules is seen histologically in many diseases, and has been described in conditions as diverse as diabetes, poisoning and decompression injury. The emboli in these conditions, however, are few and of little clinical significance. The chief cause of clinically significant fat embolism is trauma to fat-containing soft or bony tissue and the commonest group of injuries implicated are fractures of the pelvis and long bones. Although pathological and experimental evidence suggests fat embolism occurs with all such fractures, 1 only a proportion develop a recognisable systemic reaction -the fat embolism syndrome.
The fat embolism syndrome exhibits a spectrum of severity, and can present in three clinical forms -the subclinical, non-fulminant and fulminant forms. 1 Subclinical fat embolism syndrome occurs in more than 50070 of patients with pelvic or long bone fractures and is characterised by a decreased Pa02 and minor haematological changes about three days after injury.2.3 The non-fulminant subacute form is the classical clinical presentation and occurs in 1-5070 of patients with pelvic or long bone fractures, the onset being delayed from 1-6 days following injury. The complete syndrome consists of respiratory failure, fever, tachycardia, petechiae and signs of central nervous system embolism. Investigations reveal thrombocytopenia and other coagulation abnormalities, inexplicable anaemia and pulmonary alveolar and interstitial opacities on chest Xray. Unfortunately all of these changes can follow injury for a variety of other reasons and the diagnosis remains a clinical one. 4 There is no pathognomonic test. With modern supportive therapy a number of series claim a 100070 survival rate. 5 ,6 This so-called complete or classical variant is more the exception and incomplete or partial syndromes are the commonest presentation: for example, the petechial rash only occurs in 25070 of patients. 4 In contrast to these two forms, the fulminant fat embolism syndrome develops suddenly, within a few hours of injury and progresses severely and rapidly with often a fatal termination. Although most authors mention this form of presentation, there has been little discussion in the literature and the subject is illdefined and controversial.
HISTORY
The first human histological description of fat embolism was made by Zenker in 1886 and the first clinical diagnosis of the syndrome by Von Bergmann in 1873. I It is not clear who first described the fulminant form of this condition, but Peltier says that Von Bergmann was aware that shock and rapid death could occur following fat embolism. 7 Many early writers were impressed by the frequent association of hypotension with fat embolism but it is probable that the majority of these cases were oligaemic rather than embolic in origin. Grondahl, in 1911, introduced the term, "cardiac syndrome" to describe the early acute onset of tachycardia and hypotension seen with fat embolism, and like many previous and subsequent writers attributed it to blockage of the pulmonary arteries by faLl Others considered coronary fat emboli were of significance and could cause cardiac "paralysis", whereas Porter, as a result of his observations during the First World War, suggested that embolic vasomotor centre damage was the cause of the so-called "cardiac syndrome" .1
The current classification of the fat embolism syndrome into subclinical, subacute and fulminant forms was introduced by Sevitt in 1962.1 However, he felt the "cardiac syndrome" was a myth and that hypotension only occurred rarely as a terminal event due to cerebral embolism. He attached no clinical importance to pulmonary emboli apart from them being a source of systemic cerebral embolism. According to Sevitt the essence of the fulminant form is the early onset of cerebral symptoms and rapid development of coma, with death commonly occurring within one to three days. He stressed that the majority of cases were only diagnosed post mortem, and that the onset of the coma was sometimes masked by general anaesthesia and death mistaken for anaesthetic misadventure.
Contrary to Sevitt's view, Peltier believes the fat embolism syndrome is essentially a pulmonary disease and emphasises that fat emboli are capable of causing acute cor pulmonale. 7 Besides simple mechanical blockage from the fat globules he suggests that humoral and cellular factors, such as vasoactive 
PATHOPHYSIOLOGY
Although it has been generally accepted since Busch's work in 1866 that the bone marrow is the chief source of embolic fat following fracture the contribution of plasma and tissue lipid has not been determined. I ,4 Whatever their origin, experimental and pathological studies have shown emboli enter the circulation within seconds of injury.1 The acute pathophysiological effects of these emboli are poorly understood, but coagulation alterations, red blood cell aggregation and adherence of platelets all probably occur, producing an embolic complex. 4 On reaching the lungs the larger elements are filtered out by the pulmonary circulation but globules up to 20 microns pass through because of their deformable, semi-fluid consistency.4 Other routes for systemic emboli have also been suggested,1
The acute effects of obstructive pulmonary fat emboli must have similar haemodynamic consequences to thrombo-emboli. The pulmonary circulation has enormous compensatory capacity due to capillary recruitment, and moderate degrees of occlusion can be accommodated with only a slight rise in vascular resistance. If obstruction worsens, a raised right ventricular systolic pressure matches the increased pulmonary resistance and maintains a near-normal blood flow. This has been demonstrated experimentally in normal dogs who were able to maintain 75070 of control pulmonary blood flow through only 20% of the pulmonary arterial tree. ID Due to the plastic nature of the emboli the increased right ventricular pressure forces some of them through the pulmonary capillaries and occl usion may be temporary. I When the compensatory capabilities of the pulmonary circulation and right heart have been exceeded, however, acute cor pulmonale occurs. This is manifested clinically by hypotension and a raised central venous pressure. Besides pure mechanical obstruction pulmonary fat emboli may cause vasoconstriction via reflex and humoral means, although this has been discounted in pulmonary thrombo-embolism.!! The acute respiratory alterations following pulmonary embolism are dyspnoea, tachypnoea, and hypoxaemia. Dyspnoea and tachypnoea result from both the hypoxaemia and mechanical stimulation of receptors in the pulmonary vasculature, the reflex being mediated by the vagus nerves. The hypoxaemia occurs from ventilation -perfusion inequality.!2 Systemic emboli are distributed in proportion to each organ's share of the cardiac output. As the brain has a high blood flow which is maintained in the face of haemorrhagic shock, cerebral fat embolism occurs frequently. This reasoning could also apply to the coronary circulation but the clinical significance of coronary fat emboli is not clear."
A number of investigators have studied the acute haemodynamic and respiratory effects of experimental fat embolism using a variety of animal models.!3-!7 Peltier was the first to compare the pathological and physiological changes which occur after injection of neutral fat and free fatty acids. 13 He found that neutral fat caused death as a result of pulmonary vascular obstruction whereas fatty acids produced chemical pneumonitis similar to that seen with the classical variant of human fat embolism. In this latter case, local pulmonary lipolysis produces the toxic free fatty acids.
Most animal studies have shown an immediate fall in cardiac output and systemic blood pressure coupled with an increase in pulmonary artery pressure and hypoxaemia. Some studies have shown massive pulmonary oedema, often in association with a raised haematocrit.!4,!7
Breucke, like many investigators, showed that moderate hypovolaemia worsened the haemodynamic consequences considerably, with lethal results in all his animals within three hours.!4 Clinically this finding would suggest that non-lethal, revers able degrees of fat embolism could potentiate co-existing shock and cause death. The validity of this hypothesis is supported by the study of a large series of traumatised patients with fat embolism where the mortality rate was directly related to the extent of the hypovolaemic shock.4 This deleterious effect of haemorrhagic shock on fat embolism could be due to a reduction of the compensatory capacity of the right heart from a reduced preload, an increase in the quantity or obstructive capability of pulmonary emboli, or an increase in the number or harmful distribution of systemic emboli. It is probable that the effect is multifactorial.
CLINICAL FEATURES
Recognised clinical features of fat embolism are the rapid onset, soon after injury, of embolic neurological changes, acute cor pulmonale and acute respiratory failure. The condition is said to occur more commonly with multiple fractures and is usually rapidly fatal. 4 Unlike the subacute variety, petechiae are usually absent.!
The majority of case reports consistent with the fat embolism syndrome describe the rapid onset of neurological sequelae associated with respiratory failure.!,!8,!9 This appears to be an accelerated version of classical fat embolism differing only in severity and rapidity of onset. Sometimes the post-traumatic latent period is so short that the patient is admitted to hospital comatose. Other common presentations are epileptiform fits, choreo-athetoid movements, hemiparesis, acute psychosis and failure to regain consciousness after a general anaesthetic.! Acute right heart failure associated with hypotension, which was frequently described by earlier writers is only occasionally reported in the recent literature.!9 This is surprising, considering Peltier's statement "with few exceptions clinicians have emphasised the high incidence of profound shock in patients dying soon after injury with fat embolism" .20 The clinical effects of acute cor pulmonale are tachycardia, dyspnoea, tachypnoea, hypoxaemia, hypotension and a raised central venous pressure. Anginal chest pain, a loud pulmonary heart sound and increased right ventricular impulse, which are signs of pulmonary hypertension, are sometimes seen with massive thrombo-embolus and may have the same significance with fat embolism.
Acute respiratory failure due to ventilation per fusion inequality can be a result of shock, pulmonary vascular obstruction and pulmonary oedema. The latter may occur insidiously2! or suddenly, 22 similar to the overwhelming oedema seen with severe head injuries.
An abnormal bleeding tendency may occur. 22
DIAGNOSIS
The diagnosis of the fulminant fat embolism syndrome, like the subacute variety, is a clinical one, as there is no definite test apart from autopsy. Most authors who mention fulminant fat embolism stress that the majority of cases are diagnosed postmortem, but with a greater awareness of the condition and modern investigative techniques this should not be so.
An ECG may reflect the acute cor pulmonale or myocardial ischaemia 7 and chest Xray will show pulmonary oedema. Arterial gas analysis will reveal hypoxaemia and a normal or low PaC02 and coagulation studies may be abnormal. The presence of fat globules in tracheal aspirate is said to be diagnostic of pulmonary fat embolism. 4 As these cases usually occur with multiple trauma, the chief problem is, often, to distinguish between primary intra-cranial injury and embolic neurological phenomena, and shock from other causes and acute cor pulmonale. With the former, clinical features and a CT scan should delineate the problem.
The differentiation between hypovolaemic shock and acute cor pulmonale can be made by estimation of the CVP. Estimation of right atrial and pulmonary wedge pressures will distinguish between cardiogenic shock, from myocardial injury or pericardial tamponade, and shock due to cor pulmonale. This manoeuvre will also distinguish between pulmonary oedema associated with high or low pulmonary capillary pressure.
Lung scanning and pulmonary angiography presumably would be of the same value as with thrombo-embolism, but it is doubtful that there could be time for these investigations in the more severe forms of this condition. TREATMENT The mainstays of the management of fulminant fat embolism syndrome are prevention and supportive therapy. Many authors have suggested the possibility of an individual susceptibility,4,23 and, if this is so, may allow the development of more effective prophylaxis. Early correction of shock and fracture immobilisation are important in prevention, and oxygen therapy is thought to limit the severity of the syndrome. 3 Some writers have advocated the use of a tourniquet above the fracture site,23 but this has been associated with fatal massive fat and thromboembolism. 22 Like subacute fat embolism, therapy of the established condition has been chiefly supportive.
Acute respiratory failure due to pulmonary oedema is usually adequately managed with oxygen therapy, diuresis, IPPV and PEEP, but supportive therapy for severe acute cor pulmonale is rarely effective. Inotropic infusion, with judicious fluid loading, would seem the most appropriate approach and theoretically an agent with pulmonary vasodilating qualities, such as isoproterenol, would aid the passage of emboli with relief of pulmonary obstruction.
The high mortality of this syndrome underlines the inadequacy of its current management and more definitive measures need to be developed. Emulsification of emboli has been attempted 23 but has not been successful, although the concept retains theoretical appeal. Cardiac and pulmonary fat embolectomy for suspected fat embolism has been reported 24 and seems justifiable as with massive thrombo-embolism, when a patient is dying from pulmonary vascular obstruction.
